Striking an 11th-hour deal to avoid a highly anticipated bellwether trial over the nationwide opioid epidemic, three drug distributors and one manufacturer reached a $260 million settlement Monday with two Ohio counties.
Read moreNegotiations aimed at reaching a major settlement in the nation’s opioid litigation reached an impasse Friday.
Read moreA 23-year-old online drug dealer was sentenced Wednesday to 15 years in prison for selling counterfeit oxycodone pills laced with fentanyl that caused the overdose death of a La Jolla resident.
Read moreJury selection moved forward Wednesday in a bellwether trial over the nationwide opioid epidemic after the federal judge overseeing the sprawling case rejected an effort by drug manufacturers and distributors to postpone the trial.
Read more
The opioid crisis cost the U.S. economy $631 billion from 2015 through last year — and it may keep getting more expensive, according to a study released Tuesday by the Society of Actuaries.
Read more
The Oklahoma judge that awarded the state $572 million in a bellwether opioid crisis verdict against Johnson & Johnson admitted Tuesday to committing a $107 million calculation error.
Read moreJury selection will begin Wednesday in a major bellwether trial testing the first of thousands of claims filed by local governments against pharmaceutical companies over the nation’s opioid epidemic.
Read moreThe Pennsylvania Manufacturers’ Association Insurance Co. sued North Carolina Mutual Wholesale Drug Co. in federal court, claiming it has no duty to indemnify or defend the wholesaler, which is facing 69 opioid lawsuits in Ohio, 56 of which were brought by counties in North Carolina.
Read more
A judge will halt lawsuits against Purdue Pharma and its owners for six months in hopes of finalizing a settlement over the OxyContin maker’s role in the national opioid crisis, he said Friday.
Read more
How much members of the Sackler family should be held accountable for the role their company, Purdue Pharma, played in the nation’s opioid crisis will be at the center of a hearing Friday in federal bankruptcy court.
Read moreThe Sixth Circuit on Thursday denied Ohio’s request to stop an opioid trial that will test the first of thousands of claims in the state against pharmaceutical companies.
Read moreA Philadelphia nonprofit’s plan to open the nation’s first supervised injection site for drug users was given the green light Wednesday when a federal judge ruled that such establishments do not violate federal law.
Read more
Johnson & Johnson on Tuesday said it had reached an agreement worth more than $20 million with two Ohio counties, becoming the latest company to settle a lawsuit to get out of the first federal trial over the nation’s opioids crisis.
Read more
By the time drug enforcement agents swooped into his small medical office in Martinsville, Virginia, in 2017, Dr. Joel Smithers had prescribed about half a million doses of highly addictive opioids in two years.
Read moreThe federal judge overseeing thousands of cases at the center of an upcoming nationwide opioid trial in Ohio has rejected a motion by drug distributors, pharmacies and retailers to recuse himself.
Read moreConsumer products giant Johnson & Johnson is appealing an Oklahoma judge’s $572 million order against the company and its subsidiaries for helping fuel the state’s opioid crisis.
Read more
Owners of OxyContin maker Purdue Pharma expressed sympathy but not responsibility for the nation’s opioid crisis as the company filed for bankruptcy protection late Sunday night, in a move to settle some 2,600 lawsuits — most from state and local governments.
Read moreAttorneys for eight drug distributors, pharmacies and retailers facing trial next month for their roles in the opioid crisis want to disqualify the federal judge overseeing their cases, saying he has shown bias in his effort to obtain a multibillion-dollar global settlement.
Read moreThe family that owns OxyContin maker Purdue Pharma used Swiss and other hidden accounts to transfer $1 billion to themselves, New York state’s attorney general contends in court papers filed Friday.
Read moreThe Tennessee Court of Appeals ruled the state may sue opioid manufacturers under the Drug Dealer Liability Act, finding the companies cannot knowingly seek and oversupply doctors and pharmacies with the drugs for the “purpose of diversion” and then “cynically invoke their status as otherwise lawful companies to avoid civil liability.”
Read more